PANTHERx Specialty Pharmacy, the industry leading independent national specialty pharmacy, has been selected by Paratek Pharmaceuticals, Inc. as a limited pharmacy network provider of its new once-daily oral antibiotic, Nuzyra™ (omadacycline). Nuzyra™ is a tetracycline class antibacterial approved to treat adults with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI). […]

We are excited to announce that PANTHERx Specialty Pharmacy has been selected as a finalist in the category of Retail/Independent/Hospital and Health System Specialty Pharmacies for the 2019 Specialty Pharmacy Patient Choice Awards. Our status in this category is a direct result of our outstanding patient satisfaction scores from the Zitter Insights Specialty Pharmacy Patient […]

The Press Release that follows was published by Cardinal Health to formally announce the collaboration between PANTHERx Specialty Pharmacy and Cardinal Health. To read the official press release, click here: https://www.prnewswire.com/news-releases/cardinal-health-specialty-solutions-strengthens-cell-and-gene-therapy-offering-with-pantherx-specialty-pharmacy-collaboration-300839030.html To meet the growing needs of the market, Cardinal Health Specialty Solutions has strengthened its cell and gene therapy capability with a coordinated suite […]

PANTHERx® Specialty Pharmacy’s Chairman & CEO, Dr. Gordon J. Vanscoy, and PANTHERx®’s Manager of Clinical Programs, Dr. Christa Eans, will lead a Live CE Webinar as part of the American Journal of Managed Care® (AJMC) and the Pharmacy Times Continuing Education™. The webinar, titled, The Clinical and Managed Care Implications of X-Linked Hypophosphatemia will be […]

PANTHERx® Specialty Pharmacy, The Rare Disease Specialty Pharmacy®, and RxCrossroads™ by McKesson, the leading commercial solutions partner for life sciences companies, announced their collaborative program to simplify the channel for precision medicine therapies. Recognizing a significant unmet need for cell and gene therapy programs, as well as a deep pipeline of products that are set […]